Form 4: Solid Biosciences CFO Kevin Tan Reports Stock Transactions
SEC Form 4 Filing
Solid Biosciences CFO Kevin Tan reports the vesting of restricted stock units and subsequent sale of shares to cover withholding taxes.
Summary
- Kevin Tan, CFO and Treasurer of Solid Biosciences, reported transactions involving the company's stock.
- On January 9, 2025, 11,250 restricted stock units vested and converted to common stock.
- Following the vesting, Mr. Tan sold 4,073 shares on January 10, 2025, at a price of $3.8913 per share.
- The sale was to cover withholding taxes and was not a discretionary trade.
- After these transactions, Mr. Tan beneficially owns 24,789 shares of common stock.
Sentiment
Score: 5
Explanation: The document reflects routine insider transactions and does not indicate any significant positive or negative sentiment.
Management Comments
- The sale of shares was to cover withholding taxes and was not a discretionary trade by Mr. Tan.
Industry Context
This is a routine filing related to executive compensation and stock ownership, common in publicly traded companies.
Comparison to Industry Standards
- Form 4 filings are standard practice for reporting insider transactions in publicly traded companies.
- The vesting schedule of the restricted stock units is typical for executive compensation packages.
- The sale of shares to cover withholding taxes is a common occurrence after vesting events.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they are related to executive compensation and do not indicate a change in the company's fundamentals.
Key Dates
| Date | Description |
|---|---|
| 01/09/2023 | Date of grant for the restricted stock units that vest over four years. |
| 05/31/2024 | Date of acquisition of 4,152 shares under the Employee Stock Purchase Plan. |
| 11/29/2024 | Date of acquisition of 4,152 shares under the Employee Stock Purchase Plan. |
| 01/09/2025 | Date of vesting of 11,250 restricted stock units. |
| 01/10/2025 | Date of sale of 4,073 shares to cover withholding taxes. |
| 01/13/2025 | Date of filing of the Form 4. |
Keywords
Solid Biosciences, SLDB, Kevin Tan, CFO, Stock Transactions, Restricted Stock Units, Vesting, Share Sale, Form 4, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.